Pandemic Prevention Platform (P3)

The summary for the Pandemic Prevention Platform (P3) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the DARPA Biological Technologies Office, which is the U.S. government agency offering this grant.

Pandemic Prevention Platform (P3): DARPA is soliciting innovative research proposals to develop an end-to-end platform capability for preventing a pandemic threat in <60 days. Recent advances in medical countermeasures have formed a strong foundation, enabling the creation of a true end-to-end pandemic prevention platform. However, experience gained from conventional responses to emerging infectious diseases (MERS, SARS, dengue, chikungunya, Ebola) has demonstrated that significant bottlenecks hinder the rapid response to an emerging infectious threat . Current challenges include the ability to rapidly produce virus needed to test and evaluate therapies, to obtain high potency antibodies within the first weeks of an outbreak, or to scale delivery methods into humans to produce protective levels inside the patient.